APRE - Aprea Therapeutics, Inc.
1.62
-0.034 -2.086%
Share volume: 13,837
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.65
-0.03
-0.02%
Summary score
46%
Profitability
35%
Dept financing
31%
Liquidity
50%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-32.23%
Return on sales
-4701.46%
Return on invested capital
0%
Total debt ratio
32.05%
Debt ratio change over timeo
0%
Current Ratio
7.64%
Quick Ratio
0%
Cash Position Ratio
7.42%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-12.69%
Return on sales
-1058.85%
Return on invested capital
0%
Total debt ratio
16.36%
Debt ratio change over timeo
0%
Current Ratio
8.75%
Quick Ratio
0%
Cash Position Ratio
8.55%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-13.22%
Return on sales
-1567.43%
Return on invested capital
0%
Total debt ratio
19.48%
Debt ratio change over time
0%
Current Ratio
7.01%
Quick Ratio
0%
Cash Position Ratio
6.8%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | APRE | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 14.82% | 9.25% | 0% |
| Return on assets | -32.23% | 4.21% | 3.01% | 0% |
| Return on sales | -4701.46% | 27.61% | 25.13% | 0% |
| Return on invested capital | 0% | 8.25% | 9.21% | 0% |
| Profitability | 0% | 97% | 81% | 0% |
| Total debt ratio | 32.05% | 81.46% | 59.72% | 0% |
| Debt ratio change over time | 0% | -9.8% | -49.67% | 0% |
| Dept financing | 35% | 25% | 18% | 0% |
| Current Ratio | 8.75% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 8.55% | 0.13% | 0.46% | 0% |
| Liquididy | 50% | 28% | 31% | 0% |
| Short-term ratios | APRE | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -12.69% | 4.34% | 2.26% | 0% |
| Return on sales | -1058.85% | 28.22% | 23.48% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 0% |
| Total debt ratio | 16.36% | 81.06% | 60.18% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 30% | 25% | 19% | 0% |
| Current Ratio | 8.75% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 8.55% | 0.13% | 0.46% | 0% |
| Liquididy | 50% | 29% | 27% | 0% |
